A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years
Introduction. Polycystic ovary syndrome (PCOS) is a common disorder in reproductive age. This pilot study investigated the effects of myoinositol (MI) treatment on metabolic and cardiovascular profile in PCOS women over 30 years of age. Methods. Between 2015 and 2016, 50 women with diagnosis of PCOS...
Saved in:
| Main Authors: | Saghar Salehpour, Leila Nazari, Sedighe Hoseini, Nasrin Saharkhiz, Fatemeh Ghazi, Mohammad Reza Sohrabi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2016/7493147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study
by: Pedro-Antonio Regidor, et al.
Published: (2016-01-01) -
Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women
by: Ali Cenk Ozay, et al.
Published: (2016-01-01) -
Corrigendum to “Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women”
by: Ali Cenk Ozay, et al.
Published: (2018-01-01) -
Systematic analysis of the pharmacology of myoinositol and D-chiroinositola
by: T. E. Bogacheva, et al.
Published: (2024-06-01) -
Corrigendum to “Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy”
by: Pietro Cavalli, et al.
Published: (2018-01-01)